Cargando…

Development of a deprescribing manual for frail older people for use in the COFRAIL study and in primary care

INTRODUCTION: Many older adults are affected by multimorbidity and subsequent polypharmacy which is associated with adverse outcomes. This is especially relevant for frail older patients. Polypharmacy may be reduced via deprescribing. As part of the complex intervention in the COFRAIL study, we deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mann, Nina-Kristin, Schmiedl, Sven, Mortsiefer, Achim, Bencheva, Veronika, Löscher, Susanne, Ritzke, Manuela, Drewelow, Eva, Feldmeier, Gregor, Santos, Sara, Wilm, Stefan, Thürmann, Petra A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452796/ https://www.ncbi.nlm.nih.gov/pubmed/36091625 http://dx.doi.org/10.1177/20420986221122684

Ejemplares similares

Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial
por: Mortsiefer, Achim, et al.
Publicado: (2023)

Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care
por: Mortsiefer, Achim, et al.
Publicado: (2020)

Development of a shared decision-making intervention to improve drug safety and to reduce polypharmacy in frail elderly patients living at home
por: Drewelow, E., et al.
Publicado: (2022)

Shared decision making and patient-centeredness for patients with poorly controlled type 2 diabetes mellitus in primary care—results of the cluster-randomised controlled DEBATE trial
por: Wollny, Anja, et al.
Publicado: (2021)

Deprescribing in Frail Older People: A Randomised Controlled Trial
por: Potter, Kathleen, et al.
Publicado: (2016)

How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
por: Mantelli, Sophie, et al.
Publicado: (2018)

Audiovisual teleconsultation for patients with epilepsy in primary care in rural Germany: a pilot study on feasibility and acceptance
por: Feldmeier, Gregor, et al.
Publicado: (2022)

Comparing Predictions of a PBPK Model for Cyclosporine With Drug Levels From Therapeutic Drug Monitoring
por: Zapke, Sonja E., et al.
Publicado: (2021)

Handlungsempfehlungen für den Einsatz von Familienkonferenzen im hausärztlichen Bereich - ein Scoping Review
por: Kalitzkus, Vera, et al.
Publicado: (2022)

Loxapine for Treatment of Patients With Refractory, Chemotherapy-Induced Neuropathic Pain: A Prematurely Terminated Pilot Study Showing Efficacy But Limited Tolerability
por: Schmiedl, Sven, et al.
Publicado: (2019)

Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
por: Jamieson, Hamish, et al.
Publicado: (2023)

Improvement of primary health care of patients with poorly regulated diabetes mellitus type 2 using shared decision-making – the DEBATE trial
por: Drewelow, Eva, et al.
Publicado: (2012)

Development of an algorithm to detect and reduce complexity of drug treatment and its technical realisation
por: Wurmbach, Viktoria S., et al.
Publicado: (2020)

A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues
por: Hasford, J., et al.
Publicado: (2021)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

Patient-centered communication and shared decision making to reduce HbA1c levels of patients with poorly controlled type 2 diabetes mellitus - results of the cluster-randomized controlled DEBATE trial
por: Wollny, Anja, et al.
Publicado: (2019)

General practitioners treating their own family members: a cross-sectional survey in Germany
por: Mücke, Natalie Alida, et al.
Publicado: (2022)

Patient information leaflets: informing or frightening? A focus group study exploring patients’ emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices
por: Herber, Oliver Rudolf, et al.
Publicado: (2014)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

HIOPP-6 – a pilot study on the evaluation of an electronic tool to assess and reduce the complexity of drug treatment considering patients’ views
por: Wurmbach, Viktoria S., et al.
Publicado: (2022)

Prevalence and patient-rated relevance of complexity factors in medication regimens of community-dwelling patients with polypharmacy
por: Wurmbach, Viktoria S., et al.
Publicado: (2022)

Correction to: Prevalence and patient‑rated relevance of complexity factors in medication regimens of community dwelling patients with polypharmacy
por: Wurmbach, Viktoria S., et al.
Publicado: (2022)

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
por: Rottenkolber, Marietta, et al.
Publicado: (2015)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial—outcomes of the Opti-med study
por: Etherton-Beer, Christopher, et al.
Publicado: (2023)

HbA1c as a shared treatment goal in type 2 diabetes? A secondary analysis of the DEBATE trial
por: Santos, Sara, et al.
Publicado: (2023)

Deprescribing in Palliative Cancer Care
por: Hedman, Christel, et al.
Publicado: (2022)

Symposium Abstract Deprescribing in Psychiatry
por: Mudgal, Varchasvi, et al.
Publicado: (2022)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children
por: Schmiedl, Sven, et al.
Publicado: (2014)

Clinical utility of overviews on adverse events of pharmacological interventions
por: Sachse, Thilo, et al.
Publicado: (2023)

Assessing the quality of evidence on safety: specifications for application and suggestions for adaptions of the GRADE-criteria in the context of preparing a list of potentially inappropriate medications for older adults
por: Mathes, Tim, et al.
Publicado: (2022)

Older people’s attitudes towards deprescribing cardiometabolic medication
por: Crutzen, Stijn, et al.
Publicado: (2021)

Impact of timing and combination of different BNT162b2 and ChAdOx1-S COVID-19 basic and booster vaccinations on humoral immunogenicity and reactogenicity in adults
por: Dedroogh, Simon, et al.
Publicado: (2023)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
por: Kaas Oldenburg, Lykke I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s2orvdu0q882f5k6ii7lg4mj8u